Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors - PubMed (original) (raw)
Review
Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors
Vincenzo Ficarra et al. Eur Urol. 2010 Nov.
Abstract
Context: In the last few years, the treatment of renal cell carcinoma (RCC) has progressed significantly, and some histopathologic issues have become important for selection and follow-up after medical and surgical therapies.
Objective: The aim of this collaborative article is to review the most recent literature on the role of traditional histopathologic features obtained from renal core biopsy or nephrectomy specimens in the management of confined, locally advanced, and metastatic RCC.
Evidence acquisition: A nonsystematic review of the literature was performed in April 2010 using the Medline database. Multiple free-text searches were performed for the following items: renal cell carcinoma, clear cell, papillary, chromophobe, histologic* subtype*, histotype*, nuclear grade*, necrosis, sarcomatoid differentiation, biopsy, molecular marker*, and cytogenetic marker*. A total of 2369 records were retrieved from Medline, and 263 full-text studies were considered and partially included in the present review. A panel of experts reached consensus on the main subheadings of this paper.
Evidence synthesis: Core needle biopsies can provide important information that is useful to avoid the overtreatment of benign tumors and to help plan watchful waiting or minimally invasive treatments in selected patients. Tumor histotype is fundamental in the pathologic report. In the context of integrated prognostic systems, the combination of the most important clinical and pathologic factors (TNM stage, Fuhrman nuclear grade, presence of necrosis, microvascular invasion, and sarcomatoid dedifferentiation) allows us to reach a high prognostic accuracy. These models can be used to select patients suitable for adjuvant protocols, to design an appropriate follow-up schedule, and to provide careful patient counseling. Molecular and cytogenetic markers should be further evaluated.
Conclusions: The histopathologic definition of parenchymal epithelial renal tumors is fundamental to plan the management and follow-up of patients with locally confined, locally advanced, and metastatic RCC.
Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
- Peering through the microscope lens into the future.
Tollefson MK, Thompson RH. Tollefson MK, et al. Eur Urol. 2010 Nov;58(5):669-70. doi: 10.1016/j.eururo.2010.08.046. Epub 2010 Sep 15. Eur Urol. 2010. PMID: 20846782 No abstract available.
Similar articles
- [Renal-cell carcinoma. The basic concepts].
Reis M, Guimarães M. Reis M, et al. Acta Med Port. 1999 Jan-Mar;12(1-3):81-5. Acta Med Port. 1999. PMID: 10423878 Portuguese. - Prognostic factors and selection for clinical studies of patients with kidney cancer.
Lam JS, Klatte T, Kim HL, Patard JJ, Breda A, Zisman A, Pantuck AJ, Figlin RA. Lam JS, et al. Crit Rev Oncol Hematol. 2008 Mar;65(3):235-62. doi: 10.1016/j.critrevonc.2007.08.003. Epub 2007 Oct 10. Crit Rev Oncol Hematol. 2008. PMID: 17931881 Review. - Peering through the microscope lens into the future.
Tollefson MK, Thompson RH. Tollefson MK, et al. Eur Urol. 2010 Nov;58(5):669-70. doi: 10.1016/j.eururo.2010.08.046. Epub 2010 Sep 15. Eur Urol. 2010. PMID: 20846782 No abstract available. - Epidemiology, clinical staging, and presentation of renal cell carcinoma.
Decastro GJ, McKiernan JM. Decastro GJ, et al. Urol Clin North Am. 2008 Nov;35(4):581-92; vi. doi: 10.1016/j.ucl.2008.07.005. Urol Clin North Am. 2008. PMID: 18992612 Review. - Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC, Gudas LJ, Bok D, Rando R, Nanus DM, Tickoo SK. Zhan HC, et al. Clin Cancer Res. 2003 Oct 15;9(13):4897-905. Clin Cancer Res. 2003. PMID: 14581364
Cited by
- CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
Wang K, Dong L, Li S, Liu Y, Niu Y, Li G. Wang K, et al. BMC Cancer. 2024 Jan 30;24(1):148. doi: 10.1186/s12885-024-11870-1. BMC Cancer. 2024. PMID: 38291357 Free PMC article. - Preoperative low-density lipoprotein cholesterol as a predictor of favorable prognosis in patients with clear cell renal cell carcinoma.
Mei Y, Chen Z, Wang X, Xu R, Lu H. Mei Y, et al. Transl Cancer Res. 2023 Jun 30;12(6):1380-1391. doi: 10.21037/tcr-22-2705. Epub 2023 Jun 13. Transl Cancer Res. 2023. PMID: 37434674 Free PMC article. - Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82).
Tabourin T, Pinar U, Parra J, Vaessen C, Bensalah CK, Audenet F, Bigot P, Champy C, Olivier J, Bruyere F, Doumerc N, Paparel P, Parier B, Nouhaud FX, Durand X, Lang H, Branger N, Long JA, Durand M, Waeckel T, Charles T, Cussenot O, Xylinas E, Boissier R, Tambwe R, Patard JJ, Bernhard JC, Roupret M. Tabourin T, et al. Ann Surg Oncol. 2022 Oct;29(11):7218-7228. doi: 10.1245/s10434-022-12052-8. Epub 2022 Jul 3. Ann Surg Oncol. 2022. PMID: 35780452 - Can preoperative neutrophil lymphocyte ratio predict malignancy in patients undergoing partial nephrectomy because of renal mass?
Gorgel SN, Ozer K, Kose O, Dindar AS. Gorgel SN, et al. Int Braz J Urol. 2018 May-Jun;44(3):461-466. doi: 10.1590/S1677-5538.IBJU.2017.0225. Int Braz J Urol. 2018. PMID: 29211406 Free PMC article. - Tumor size, stage and grade alterations of urinary peptidome in RCC.
Chinello C, Cazzaniga M, De Sio G, Smith AJ, Grasso A, Rocco B, Signorini S, Grasso M, Bosari S, Zoppis I, Mauri G, Magni F. Chinello C, et al. J Transl Med. 2015 Oct 20;13:332. doi: 10.1186/s12967-015-0693-8. J Transl Med. 2015. PMID: 26482227 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous